Skip to main content
I

Invitae

Invitae, in partnership with Labcorp, offers an online platform for ordering more than 6,500 FDA‑cleared and CLIA‑certified genetic tests across specialties such as oncology, cardiology, neurology, and rare disease. The service leverages Labcorp’s nationwide patient‑service centers for specimen collection and provides integrated billing, insurance verification, and access to board‑certified genetic counselors who help interpret results and deliver gene‑specific medical management guides. This streamlined workflow enables clinicians and patients to incorporate comprehensive genetic insights into diagnosis and treatment planning with broad health‑plan coverage.

San Francisco, United StatesFounded 201068950K+ followers
Updated 2 months ago

Funding

$1.1B raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

S
Funding rounds are not available yet.

Founders

Product

Problem

Patients and clinicians often lack convenient, affordable access to comprehensive genetic testing, leading to delayed diagnoses and limited use of genetic information in routine healthcare.

Solution

Invitae, in partnership with Labcorp, provides a broad catalog of over 6,500 genetic tests that can be ordered through an online portal and processed at Labcorp’s nationwide network of patient service centers. The combined offering integrates clinical genetic testing across specialties such as oncology, cardiology, neurology, and rare disease, with most tests covered by health plans. Flexible billing options and built‑in support services—including dedicated client services, licensed genetic counselors, and result interpretation guides—help clinicians and patients navigate test selection, ordering, and result utilization. Test results are delivered electronically with accompanying gene‑specific medical management guides, enabling providers to incorporate genetic insights into diagnosis, prognosis, and treatment planning. The partnership leverages Labcorp’s extensive laboratory infrastructure and Invitae’s expertise in test development to expand access and streamline the genetic testing workflow.

Target Audience

Primary customers are healthcare providers—including physicians, genetic counselors, and hospital systems—who need reliable, reimbursable genetic testing for patient diagnosis and management, as well as patients seeking accessible genetic insights.

Features

  • Catalog of 6,500+ FDA‑cleared and CLIA‑certified genetic tests covering oncology, cardiology, neurology, rare diseases, and more
  • Online ordering platform with integrated billing and insurance verification for streamlined provider workflow
  • Nationwide network of Labcorp patient service centers for specimen collection, reducing geographic barriers
  • Licensed, board‑certified genetic counselors available to assist clinicians and patients with test selection and result interpretation
  • Automated, gene‑specific medical management guides appended to reports to support evidence‑based care decisions
  • Secure electronic delivery of results and integration options for electronic health record systems
This profile is AI-generated and may contain inaccuracies.